CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
Commission Builds on Previous Action by Targeting More Than 300 Patents,… Read More
President Says ‘Drug Companies Are Charging Exorbitant Prices’ in Press… Read More
Lawmakers and Experts Will Discuss Solutions to Hold Big Pharma Accountable… Read More
Brand Name Drug Companies’ Price Increases in First Two Weeks of 2024… Read More
Big Pharma Giant Switches Popular Brand Name Inhaler to Authorized Generic to… Read More
Big Pharma Maintains Business-as-Usual Approach to Price-Gouging Americans to… Read More
Administration Announces Drug Makers Increased Prices Faster Than Rate of… Read More